Is Primary Tumor Excision and Specific Metastases Sites Resection Associated With Improved Survival in Stage Ⅳ Colorectal Cancer? Results From SEER Database Analysis

Abstract

Objective

We aimed to explore the prognostic value of primary tumor and specific metastases excision on survival among patients with stage IV colorectal cancer (CRC) in the Surveillance, Epidemiology, and End Results (SEER) database.

Methods

Patients with stage IV CRC were selected using SEER database between 2010 and 2013. Survival rate was calculated according to the Kaplan-Meier method, and differences between curves were tested by the log-rank test. Cox proportional hazards model was used in the multivariable analysis.

Results

Included in this study were 27 878 patients with distant metastatic CRC. Among the single organ site of metastatic CRC, patients with solitary metastasis of lung showed the highest median overall survival (OS). Both primary and metastatic sites surgical resection for patients with liver, lung, and simultaneous liver and lung metastases had better median OS. Age younger than 65 years, Asian and Pacific Islander, distal colon and rectum, and palliative primary tumor and metastatic lesions resection were associated with better OS after multivariate analysis. Palliative primary tumor and metastatic lesions resection had a significant survival benefit compared with nonsurgical group in selected patients.

Conclusion

These findings support the use of preemptive surgery in the management of highly selected metastatic CRC patients.

Keywords

stage Ⅳ colorectal cancer surgery survival SEER

Get full access to this article

View all access options for this article.

References

Siegel

RL.

Miller

KD.

Fedewa

et al. Colorectal cancer statistics, 2017. CA Cancer J Clin. 2017;67(3):177-193.doi:10.3322/caac.21395

http://www.ncbi.nlm.nih.gov/pubmed/28248415

Lin

B-R.

Chang

T-C.

Lee

Y-C.

Lee

P-H.

Chang

K-J.

Liang

J-T

. Pulmonary resection for colorectal cancer metastases: duration between cancer onset and lung metastasis as an important prognostic factor. Ann Surg Oncol. 2009;16(4):1026-1032.doi:10.1245/s10434-008-0286-3

http://www.ncbi.nlm.nih.gov/pubmed/19184237

Neeff

Hörth

Makowiec

et al. Outcome after resection of hepatic and pulmonary metastases of colorectal cancer. J Gastrointest Surg. 2009;13(10):1813-1820.doi:10.1007/s11605-009-0960-1

http://www.ncbi.nlm.nih.gov/pubmed/19593668

Van Cutsem

Cervantes

Adam

et al. ESMO consensus guidelines for the management of patients with metastatic colorectal cancer. Ann Oncol. 2016;27(8):1386-1422.doi:10.1093/annonc/mdw235

http://www.ncbi.nlm.nih.gov/pubmed/27380959

Kataoka

Kanazawa

Nakajima

Yamaguchi

Arimoto

Kohno

. Feasibility and potential benefit of preoperative chemotherapy for colorectal liver metastasis (CLM): a single-centered retrospective study. Surg Today. 2013;43(10):1154-1161.doi:10.1007/s00595-012-0410-7

http://www.ncbi.nlm.nih.gov/pubmed/23139049

Longo

WE.

Virgo

KS.

Johnson

et al. Risk factors for morbidity and mortality after colectomy for colon cancer. Dis Colon Rectum. 2000;43(1):83-91.doi:10.1007/BF02237249

http://www.ncbi.nlm.nih.gov/pubmed/10813129

Legendre

Vanhuyse

Caroli-Bosc

FX.

Pector

. Survival and quality of life after palliative surgery for neoplastic gastrointestinal obstruction. Eur J Surg Oncol. 2001;27(4):364-367.doi:10.1053/ejso.2001.1120

http://www.ncbi.nlm.nih.gov/pubmed/11417981

Kim

MS.

Chung

Ahn

et al. Clinical significance of primary tumor resection in colorectal cancer patients with synchronous unresectable metastasis. J Surg Oncol. 2014;110(2):214-221.doi:10.1002/jso.23607

http://www.ncbi.nlm.nih.gov/pubmed/24668581

Tebbutt

NC.

Norman

AR.

Cunningham

et al. Intestinal complications after chemotherapy for patients with unresected primary colorectal cancer and synchronous metastases. Gut. 2003;52(4):568-573.doi:10.1136/gut.52.4.568

http://www.ncbi.nlm.nih.gov/pubmed/12631671

10.

Seo

GJ.

Park

JW.

Yoo

et al. Intestinal complications after palliative treatment for asymptomatic patients with unresectable stage IV colorectal cancer. J Surg Oncol. 2010;102(1):94-99.doi:10.1002/jso.21577

http://www.ncbi.nlm.nih.gov/pubmed/20578086

11.

Cirocchi

Trastulli

Abraha

et al. Non-resection versus resection for an asymptomatic primary tumour in patients with unresectable stage IV colorectal cancer. Cochrane Database Syst Rev. 2012;8(8):CD008997.doi:10.1002/14651858.CD008997.pub2

http://www.ncbi.nlm.nih.gov/pubmed/22895981

12.

Kanas

GP.

Taylor

Primrose

et al. Survival after liver resection in metastatic colorectal cancer: review and meta-analysis of prognostic factors. Clin Epidemiol. 2012;4:283-301.doi:10.2147/CLEP.S34285

http://www.ncbi.nlm.nih.gov/pubmed/23152705

13.

Oweira

Petrausch

Helbling

et al. Prognostic value of site-specific metastases in pancreatic adenocarcinoma: a surveillance epidemiology and end results database analysis. World J Gastroenterol. 2017;23(10):1872-1880.doi:10.3748/wjg.v23.i10.1872

http://www.ncbi.nlm.nih.gov/pubmed/28348494

14.

Simmonds

PC.

Primrose

JN.

Colquitt

JL.

Garden

OJ.

Poston

GJ.

Rees

. Surgical resection of hepatic metastases from colorectal cancer: a systematic review of published studies. Br J Cancer. 2006;94(7):982-999.doi:10.1038/sj.bjc.6603033

http://www.ncbi.nlm.nih.gov/pubmed/16538219

15.

Schmidt

. Metastatic colorectal cancer: is surgery necessary? J Natl Cancer Inst. 2009;101(16):1113-1115.doi:10.1093/jnci/djp269

http://www.ncbi.nlm.nih.gov/pubmed/19671774

16.

Wancata

LM.

Banerjee

Muenz

DG.

Haymart

MR.

Wong

. Conditional survival in advanced colorectal cancer and surgery. J Surg Res. 2016;201(1):196-201.doi:10.1016/j.jss.2015.10.021

http://www.ncbi.nlm.nih.gov/pubmed/26850202

17.

Vargas

GM.

Sheffield

KM.

Parmar

et al. Trends in treatment and survival in older patients presenting with stage IV colorectal cancer. J Gastrointest Surg. 2014;18(2):369-377.doi:10.1007/s11605-013-2406-z

http://www.ncbi.nlm.nih.gov/pubmed/24234244

18.

Abdelsattar

ZM.

Wong

SL.

Regenbogen

SE.

Jomaa

DM.

Hardiman

KM.

Hendren

. Colorectal cancer outcomes and treatment patterns in patients too young for average-risk screening. Cancer. 2016;122(6):929-934.doi:10.1002/cncr.29716

http://www.ncbi.nlm.nih.gov/pubmed/26808454

19.

Horowitz

NS.

Miller

Rungruang

et al. Does aggressive surgery improve outcomes? Interaction between preoperative disease burden and complex surgery in patients with advanced-stage ovarian cancer: an analysis of GOG 182. J Clin Oncol. 2015;33(8):937-943.doi:10.1200/JCO.2014.56.3106

http://www.ncbi.nlm.nih.gov/pubmed/25667285

20.

Collins

Hatzaras

Schmidt

et al. Gastrectomy in advanced gastric cancer effectively palliates symptoms and may improve survival in select patients. J Gastrointest Surg. 2014;18(3):491-496.doi:10.1007/s11605-013-2415-y

http://www.ncbi.nlm.nih.gov/pubmed/24234246

21.

Culp

SH.

Schellhammer

PF.

Williams

. Might men diagnosed with metastatic prostate cancer benefit from definitive treatment of the primary tumor? A SEER-based study. Eur Urol. 2014;65(6):1058-1066.doi:10.1016/j.eururo.2013.11.012

http://www.ncbi.nlm.nih.gov/pubmed/24290503

22.

Abubaker

Latifi

Luwor

et al. Short-Term single treatment of chemotherapy results in the enrichment of ovarian cancer stem cell-like cells leading to an increased tumor burden. Mol Cancer. 2013;12:24.doi:10.1186/1476-4598-12-24

http://www.ncbi.nlm.nih.gov/pubmed/23537295

23.

Tarantino

Warschkow

Worni

et al. Prognostic relevance of palliative primary tumor removal in 37,793 metastatic colorectal cancer patients: a population-based, propensity Score-Adjusted trend analysis. Ann Surg. 2015;262(1):112-120.doi:10.1097/SLA.0000000000000860

http://www.ncbi.nlm.nih.gov/pubmed/25373464

24.

Xia

Jia

et al. Primary tumor resection is associated with improved survival in stage IV colorectal cancer: an instrumental variable analysis. Sci Rep. 2015;5:16516.doi:10.1038/srep16516

http://www.ncbi.nlm.nih.gov/pubmed/26563729

25.

Murphy

CC.

Harlan

LC.

Lund

JL.

Lynch

CF.

Geiger

. Patterns of colorectal cancer care in the United States: 1990-2010. J Natl Cancer Inst. 2015;107(10). 23 07 2015.doi:10.1093/jnci/djv198

http://www.ncbi.nlm.nih.gov/pubmed/26206950

26.

Page

AJ.

Ejaz

Spolverato

et al. Enhanced recovery after surgery protocols for open hepatectomy--physiology, immunomodulation, and implementation. J Gastrointest Surg. 2015;19(2):387-399.doi:10.1007/s11605-014-2712-0

http://www.ncbi.nlm.nih.gov/pubmed/25472030

27.

Buchs

NC.

Ris

Majno

et al. Rectal outcomes after a liver-first treatment of patients with stage IV rectal cancer. Ann Surg Oncol. 2015;22(3):931-937.doi:10.1245/s10434-014-4069-8

http://www.ncbi.nlm.nih.gov/pubmed/25201505

28.

Viganò

Capussotti

Lapointe

et al. Early recurrence after liver resection for colorectal metastases: risk factors, prognosis, and treatment. A LiverMetSurvey-based study of 6,025 patients. Ann Surg Oncol. 2014;21(4):1276-1286.doi:10.1245/s10434-013-3421-8

http://www.ncbi.nlm.nih.gov/pubmed/24346766

29.

Sabolch

Else

Griffith

et al. Adjuvant radiation therapy improves local control after surgical resection in patients with localized adrenocortical carcinoma. Int J Radiat Oncol Biol Phys. 2015;92(2):252-259.doi:10.1016/j.ijrobp.2015.01.007

http://www.ncbi.nlm.nih.gov/pubmed/25754631

30.

Ahmed

Johnson

Ahmed

Iqbal

. Advances in the management of colorectal cancer: from biology to treatment. Int J Colorectal Dis. 2014;29(9):1031-1042.doi:10.1007/s00384-014-1928-5

http://www.ncbi.nlm.nih.gov/pubmed/24953060

31.

Kopetz

Chang

GJ.

Overman

et al. Improved survival in metastatic colorectal cancer is associated with adoption of hepatic resection and improved chemotherapy. J Clin Oncol. 2009;27(22):3677-3683.doi:10.1200/JCO.2008.20.5278

http://www.ncbi.nlm.nih.gov/pubmed/19470929

Supplementary Material

Please find the following supplemental material available below.

For Open Access articles published under a Creative Commons License, all supplemental material carries the same license as the article it is associated with.

For non-Open Access articles published, all supplemental material carries a non-exclusive license, and permission requests for re-use of supplemental material or any part of supplemental material shall be sent directly to the copyright owner as specified in the copyright notice associated with the article.

0.00 MB

0.46 MB